Hyrimoz®

CVS Health Enters Biosimilars Market With New Subsidiary Cordavis
CVS Health Enters Biosimilars Market With New Subsidiary Cordavis
August 23, 2023  |  Healthcare

CVS Health has launched Cordavis, a new subsidiary focused on bringing high-quality biosimilar products to the market to reduce drug costs. Biosimilars are FDA-approved biologic medications...

READ MORE >